Richard N. Channick, MD

Associate Professor of Medicine Associate Director, MICU

CLINICAL INTERESTS:

1. Pulmonary hypertension
2. Thromboembolic disease
3. Critical care

INVESTIGATIVE INTERESTS:

1. Chronic thromboembolic pulmonary hypertension
2. Pathogenesis of primary pulmonary hypertensions
3. New therapies for pulmonary hypertension, including inhaled nitric oxide

SELECTED PUBLICATIONS:

1. Jamieson SW, Auger WR, Fedullo PF, Channick RN, Kriett JM, Tarazi RY, Moser KM. Experience and results in 150 pulmonary thromboendarterectomy operations over a 29 month period. J Thorac Cardiovasc Surg 1993;106:116-127.
2. Channick RN, Hoch RP, Newhart JW, Johnson FW, Smith CM. Improvement in hypoxemia and pulmonary hypertension following nitric oxide inhalation in a patient with end-stage pulmonary fibrosis. Am J Respir Crit Care Med 1994;149:811-4.
3. Channick RN, Newhart JW, Johnson FW, Moser KM. Inhaled nitric oxide reverses hypoxic pulmonary vasoconstriction in dogs: a practical nitric oxide delivery and monitoring system. Chest 1994;105:1842-7.
4. Channick RN. Primary pulmonary hypertension. In: Atlas of Heart Diseases. Ed. Braunwald E, Current Medicine 1995; Volume 3, pp 4.1-4.20.
5. Channick RN. Pulmonary hypertension. In: Manual of Clinical Problems in Pulmonary Medicine. Bordow RA, Moser KM, eds. Fourth edition. Little Brown and Company, 1995 pp 477-85.
6. Kerr KM, Auger WR, Fedullo PF, Channick RN, Yi ES. Moser KM. Large vessel pulmonary arteritis mimicking chronic thromboembolic disease. Am J Respir Crit Care Med 1995;152:367-73.
7. Bradley SP, Auger WR, Moser KM, Fedullo PF, Channick RN, Bloor CM. Right ventricular pathology in chronic pulmonary hypertension. Am J Cardiol 1996;78:584-7.
8. Channick RN, Newhart JN, Johnson FW, Williams PJ, Auger WR, Fedullo PF, Moser KM. Pulsed delivery of inhaled nitric oxide in patients with pulmonary hypertension: An ambulatory delivery system in initial clinical tests. Chest 1996;109:1545-9.
9. Hirsh AM, Moser KM, Auger WR, Channick RN, Fedullo PF. Unilateral thromboembolic pulmonary artery occlusion: Does it cause post-obstructive vasculopathy? Am J Respir Crit Care Med 1996;153:A90.
10. Morris TA, Auger WR, Ysrael MZ, Olson LK, Channick RN, Fedullo PF, Moser KM. Parenchymal scarring is associated with restrictive spirometric defects in patients with chronic thromboembolic pulmonary hypertension. Chest 1996;110:399-403.
11. Wilson WC, Kapelanski DP, Benumof JL, Newhart JW, Johnson FW, Channick RN. Inhaled nitric oxide (40 ppm) during one-lung ventilation, in the lateral decubitus position, does not decrease pulmonary vascular resistance or improve oxygenation in normal patients. J Cardiothorac Vasc Anesth 1997;11:172-6.